Likewise, in our study, the data demonstrated that it is the PI3K-Akt pathway that invokes CA125 expression (Fig. 5a, b) and distinguishes the postprandial pattern of cancer-derived CA125 from those observed in benign diseases (Figs. 1 and 2). The gene discussed is AKT1; the disease is cancer.